|
|
The Latest News on Alzheimer's Disease | Memory
Test Signs of Alzheimer's Found Ten Years Early
by Kathleen Fackelman,
USA Today
|
|||||||||||
|
Lars Bäckman of the Karolinska Institute in Stockholm and his colleagues grouped together the findings from 47 scientific studies. They found a pattern of subtle thinking deficits that seemed more common in people destined to get Alzheimer's. The team homed in on 1,207 older people who had been given cognitive tests years before getting a diagnosis. They compared them with 9,097 older people who had been given the same tests but who stayed healthy.
The team's meta-analysis, a powerful statistical method that culls results from many studies, revealed that the people who would later develop Alzheimer's showed small deficits in memory, a finding that fits with what is known about the way Alzheimer's affects the brain.
Full-blown Alzheimer's attacks the hippocampus, the brain's memory region, Bäckman says. But at very early stages, the disease has yet to produce serious damage: Thus forgetfulness is minor, he says. For example, people might have trouble remembering what they had for breakfast but can still keep track of important appointments.
The team also found a raft of other difficulties, a finding that suggests the disease attacks other brain regions as well. For example, people destined to get Alzheimer's scored poorly on tests of executive function, the ability to plan ahead or multitask.
The people who ended up with Alzheimer's also took longer to solve problems and did a little worse on tests of verbal ability, Bäckman and his colleagues report in the July Neuropsychology.
But the slight deficits in memory and speed could easily be written off as an age-related decline, Bäckman says. Old age itself can produce minor lapses in memory and a slowdown in mental agility, he says.
Researchers have yet to develop a test that reliably identifies people who will develop Alzheimer's in the future, says Ronald Petersen, an Alzheimer's expert at the Mayo Clinic in Rochester, Minn.
Drugs available now do not slow the disease, so there is no rush to find people at this preclinical stage. But that may change if therapies in the pipeline pan out, Petersen says. Then an early diagnosis combined with treatment could stop the disease before a great deal of damage occurs.
"We want to give people lots of time to aggressively treat this disease that makes your brain rot," Bäckman says.
More information
Alzheimer'sWhat research is being done?
Read
testimonials from scientists and physicians on MemCheck.
Give Memory For Life as a Gift
for a loved one. Actions taken today
help tomorrow.
Give the Gift of TV - Cognitive Labs and
Microsoft are partnering on a special offer.
![]() 18 cents per day/$69.95 year |
![]() ![]() 33 cents per day/$9.95 month - less than a newspaper or coffee. Read about us in ![]() |